['type 2 diabetes mellitus']
['bexagliflozin', 'sitagliptin', 'placebo for sitagliptin', 'placebo for bexagliflozin']

        Inclusion Criteria:

          -  Diagnosis of T2DM

          -  Currently taking metformin or taking metformin and one additional oral medication for
             diabetes

          -  Body Mass Index (BMI) ≤ 45 kg/m2

          -  Stable dose of blood pressure or cholesterol medications (if applicable) for at least
             30 days

        Exclusion Criteria:

          -  Hypersensitivity or other contraindication to the safe use of DPP-4 inhibitor or
             sitagliptin

          -  Diagnosis of type 1 diabetes mellitus or maturity-onset/diabetes of the young

          -  History of genitourinary tract infections

          -  Evidence of abnormal liver function

          -  History of pancreatitis

          -  Myocardial infarction, stroke or hospitalization for heart failure within 3 months of
             screening

          -  Evidence of kidney problems

          -  Pregnant or nursing
      